Erschienen in:
01.03.2015 | The Science of Prevention (JD Stekler, Section Editor)
Novel Interventions to Prevent HIV and HCV Among Persons Who Inject Drugs
verfasst von:
Phillip O. Coffin, Christopher Rowe, Glenn-Milo Santos
Erschienen in:
Current HIV/AIDS Reports
|
Ausgabe 1/2015
Einloggen, um Zugang zu erhalten
Abstract
Persons who inject drugs (PWID) are at high risk for infection with and poor outcomes from HIV and hepatitis C virus (HCV). Well-established interventions for HIV/HCV prevention among PWID include syringe access, opioid agonist maintenance treatment, and supervised injection facilities, yet these interventions remain unavailable or inadequately resourced in much of the world. We review recent literature on biomedical and behavioral interventions to reduce the burden of HIV/HCV among PWID, with an emphasis on randomized controlled trials and quasi-experimental studies. Since 2013, there have been significant advancements in utilizing antiviral therapy and behavioral interventions for prevention among PWID, including approaches that address the unique needs of couples and sex workers. In addition, there have been significant developments in pharmacotherapies for substance use and the implementation of naloxone for opioid overdose prevention. Notwithstanding multiple ongoing structural challenges in delivering HIV/HCV prevention interventions to PWID, these emerging and rigorously evaluated interventions expand possibilities for prevention among PWID.